Neurodiversity: A Brain That Works Differently

Sep 20, 2024

The term “neurodiversity” is defined by Harvard Health as “the idea that people experience and interact with the world around them in many different ways; there is no one “right” way of thinking, learning, and behaving. The word neurodiversity refers to the diversity of all people, but it is often used in the context of autism spectrum disorder (ASD), as well as other neurological or developmental conditions such as ADHD or learning disabilities.”

A lot of people, including children, struggle with the above-mentioned conditions. One of this week’s faculty members, Dr. Carissa Jackel, Assistant Professor of Pediatrics at CHOP, explains that some of the difficulties neurodiverse children often face are being misunderstood by others and having low self-esteem. Unfortunately, children with developmental disorders are frequently stigmatized due to a lack of understanding of the children’s conditions or a reluctance to take their symptoms seriously.

Educational events, such as this week’s seminar in Behavioral Pediatrics and Child Development, which took place from September 15 to 21, 2024, actively try to change societal norms and ideals around neurodiverse individuals.

The pediatric cohort, who served as faculty members, was made up of course director Dr. Nathan J. Blum (CHOP), co-course director Dr. Claudia M. Klier (Medical University of Vienna), Dr. Amanda E. Bennett (CHOP), Dr. Sandhyaa Iyengar (CHOP), Dr. Carissa Jackel (CHOP), Dr. Paul L. Plener (Medical University of Vienna), and Dr. Julia Schwarzenberg (Medical University of Vienna). The seven medical professionals from the Children’s Hospital of Philadelphia (CHOP) and the Medical University of Vienna were committed to sharing their knowledge about neurodiversity in children with the 32 fellows from 21 countries.

In Dr. Blum’s opinion, the seminar was, “a tremendous opportunity to learn about some of the most common chronic conditions affecting children’s health, development, and behavior today. Faculty and fellows from Europe, Africa, Asia, and Central America discussed evidence-informed evaluation and treatment for conditions including autism spectrum disorder, attention deficit hyperactivity disorder, mood and anxiety disorders, disruptive behavior disorders, sleep disorders, eating disorders, as well as children exposed to psychosocial trauma.”

When asked why he chose to educate young doctors from around the world pro bono, the course director explained in a passionate tone, “During the five-day OMI seminar faculty and fellows had the opportunity to develop enduring professional relationships that facilitate improvements in care around the world. Case discussions provided the opportunity to debate approaches to care despite limitations that vary across the home countries of faculty and fellows.” These words highlight that Dr. Blum values sharing his knowledge with others and encourages fellows to make the most of the networking opportunities presented during the seminar.

Even after the conclusion of this educational event, OMI faculty and fellows will continue to advocate for the inclusion of neurodiverse children and adolescents in everyday society, raise awareness for their conditions, and care for their unique needs!

Cynthia Guerra, MD

Cynthia Guerra, MD

OMI fellow from Mexico

“Language delay is one of the most frequent disorders I encounter as a pediatric neurologist, so Dr. Bennett’s lecture was especially important to me. She shared her knowledge in such a clear and understandable way that I know I will keep returning to my notes for a long time.”
Skender Malo, MD

Skender Malo, MD

OMI fellow from Albania

“As a pediatric resident, I found this course very informative. It provided me with in-depth insights into aspects of behavioral pediatrics and child development, such as autism, ADHD, and developmental screening. These insights will help me deliver quality healthcare to my patients.”
Merve Çiçek Gündoğdu, MD

Merve Çiçek Gündoğdu, MD

OMI fellow from Turkey

“I consulted Dr. Blum about the future of developmental pediatrics in my home country. We talked about the use of medication in developmental pediatric practice and the differences between my country and the USA. It was very important for me to get his advice on this issue.”